HOME >> BIOLOGY >> NEWS
Research shows high doses of acetaminophen clear rapidly and consistently from bloodstream

Ft. Washington, PA (April 1, 2003) -- Acetaminophen, the medicine in Tylenol, clears rapidly and completely from the bloodstream even in doses as high as twice the daily recommended dose, according to new research presented at the 42nd annual meeting of the Society of Toxicology recently in Salt Lake City.

"Our objective was to take what we already knew about the pharmacokinetics of acetaminophen and go a step further," explained lead investigator Cathy K. Gelotte, PhD, Executive Director, Medical and Regulatory Product Development, McNeil Consumer & Specialty Pharmaceuticals. "We wanted to see if acetaminophen is cleared at the same rate when we increased dosage beyond the recommended maximum adult daily dose of 4 g/day to 8 g/day. This study demonstrates how the body handles a higher dose and may be useful data for physicians."

The study, a double-blinded, placebo-controlled design, examined the pharmacokinetics of three dosing regimens: 4 g/day, 6 g/day, and 8 g/day. A total of 36 subjects were divided into two groups. Group I included 6 patients on placebo and 12 on acetaminophen taking 4 g/day then 6 g/day. Group II included 6 patients on placebo and 12 patients on acetaminophen taking 4 g/day then taking 8 g/day. Regimens were continued for three consecutive days, with blood sampling during the first and last dose of each daily regimen.

"Analysis of plasma acetaminophen levels showed that doses as high as 8 g/day, or twice the maximum daily recommended dose, did not accumulate and the drug was consistently cleared from the bloodstream," said Dr. Gelotte. "Moreover, it is important to note that liver enzyme values for all subjects, regardless of whether they were on the 4-, 6-, or 8 g/day regimen, stayed within normal limits throughout the study."

Dr. Gelotte emphasized that this study was undertaken to learn more about the pharmacokinetic profile of acetaminophen. It was not intended to explore the potential for increa
'"/>

Contact: Robert Murphy
rmurphy@djstorch.com
908-273-1400
D. J. Storch & Associates Inc.
1-Apr-2003


Page: 1 2

Related biology news :

1. Researchers determine genetic cause of Timothy syndrome
2. Researchers find color sensitive atomic switch in bacteria
3. Schepens Eye Research Institute receives Roadmap grant to develop center for curing eye diseases
4. Researchers identify protein promoting vascular tumor growth
5. Researchers devise potent new tools to curb ivory poaching
6. Researchers create nanotubes that change colors, form nanocarpet and kill bacteria
7. Researchers ID chlorophyll-regulating gene
8. Environmental issues center of Inland Northwest Research Alliance 4th Annual Symposium
9. Research suggests new avenue for stopping, preventing colon cancer
10. Researchers develop fast track way to discover how cells are regulated
11. Research on carbohydrate metabolism receives historical recognition

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/23/2019)... ... 23, 2019 , ... Catalent (Booth 3101), the leading global ... health products, is to launch its new OneBio SuiteSM for the integrated development, ... takes place at the Pennsylvania Convention Center in Philadelphia, from June 3-6, 2019. ...
(Date:5/21/2019)... ... May 21, 2019 , ... Experiential tourism, a trend encompassing ... over the last several years. And according to a recent report by Skift, ... In fact, more and more travelers are wanting their journeys to be authentic ...
(Date:5/21/2019)... ... May 20, 2019 , ... The ASGCT Clinical Trials Finder ... therapy throughout the United States. Data curated daily from ClinicalTrials.gov ensures the most up-to-date ... members who volunteered to assist in the development of the ASGCT Clinical Trials ...
Breaking Biology News(10 mins):
(Date:6/11/2019)... ... June 11, 2019 , ... ... from human mesenchymal stem cells (MSC-EV) are able to incorporate into human CD34+ ... a test on mice, MSC-EVs also increased the cells’ ability to lodge into ...
(Date:5/31/2019)... (PRWEB) , ... May 29, 2019 , ... For many ... the toughest forms of cancer demand breakthrough therapies. Advances in immuno-oncology have led to ... patient’s own T cells with engineered T cell receptors known as “CARs”. The CAR ...
(Date:5/31/2019)... ... May 30, 2019 , ... ... Data Integrity on July 08-09, 2019 in Boston, MA. This peer recommended interactive ... device organizations. , The training will kick off with a compendial treatment of ...
(Date:5/31/2019)... ... May 30, 2019 , ... A study released today ... system for the sustained release of human placental stem cell (HPSC)-derived conditioned medium ... to deliver CM into the injured kidney, where it helped restore function and ...
Breaking Biology Technology:
Cached News: